Padmanee Sharma, Michael Krainer, Fred Saad, Daniel Castellano, Jens Bedke, Mariusz Kwiatkowski, Akash Patnaik, Giuseppe Procopio, Paweł Wiechno, Samith Kochuparambil, Christian Thomas, José Ángel Arranz Arija, Steven L. McCune, Steinbjørn Hansen, Gedske Daugaard, Juan Ignacio Delgado Mingorance, Craig Kukard, Sumit K. Subudhi, Sreyashi Basu, Sonali Jindal, Bilal A. Siddiqui, Ana Lako, Saurabh Gupta, Viktor Fedorov, Neha P. Amin, Arancha Campos, Yumeng Wang, Justin M. David, Russell K. Pachynski. "Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial." Nature Communications, 2026. doi:10.1038/s41467-026-72242-w